The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Azienda Ospedaliera Universitaria Senese.
Recruitment status was  Recruiting
MedImmune LLC
Information provided by (Responsible Party):
Michele Maio, Azienda Ospedaliera Universitaria Senese Identifier:
First received: July 31, 2012
Last updated: NA
Last verified: July 2012
History: No changes posted
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2015
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
No publications provided by Azienda Ospedaliera Universitaria Senese

Publications automatically indexed to this study by Identifier (NCT Number):